P0897 : Efficacy of simeprevir and sofosbuvir for treatment of cirrhotic patients with genotype 1 chronic hepatitis C – a single center experience
Virendra Singh(Rayat Bahra University), Stewart Cooper(California Pacific Medical Center), Raphael B. Merriman(California Pacific Medical Center), Tim Davern(California Pacific Medical Center), Chanda Ho(California Pacific Medical Center), Adil E. Wakil(California Pacific Medical Center), Kidist Yimam(California Pacific Medical Center), Edward W. Holt(California Pacific Medical Center), T.K. Lee(California Pacific Medical Center), Thorburn Frederick(California Pacific Medical Center), Jennifer Guy(California Pacific Medical Center)
Cited by 1
Related Papers
Epidemiology and Effects of Bacterial Infections in Patients With Cirrhosis Worldwide
|Gastroenterology|2018|513
Noradrenaline vs. terlipressin in the treatment of hepatorenal syndrome: A randomized study
|Journal of Hepatology|2012|269
Oral prenylation inhibition with lonafarnib in chronic hepatitis D infection: a proof-of-concept randomised, double-blind, placebo-controlled phase 2A trial
|The Lancet Infectious Diseases|2015|262
Granulocyte Colony-Stimulating Factor in Severe Alcoholic Hepatitis: A Randomized Pilot Study
|The American Journal of Gastroenterology|2014|226
Clinical features and evolution of bacterial infection-related acute-on-chronic liver failure
|Journal of Hepatology|2020|172